Increased 18F-fluoroestradiol uptake in radiation pneumonia

Annals of Nuclear Medicine

Volumn 27, Issue 10, 2013, Pages 931-934

  Yang, Zhongyi ^a,b   Sun, Yifei ^a,b   Yao, Zhifeng ^a,b   Xue, Jing ^a,b   Zhang, Yongping ^a,b   Zhang, Yingjian ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

18F FES PET; Breast cancer; Radiation pneumonitis

Indexed keywords

ANTINEOPLASTIC AGENT; ESTRADIOL; ESTROGEN RECEPTOR; FLUORINE 18; FLUOROESTRADIOL F 18; TRACER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST METASTASIS; CASE REPORT; CHEMORADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; MEDICAL HISTORY; MIDDLE AGED; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION PNEUMONIA; WHOLE BODY CT; WHOLE BODY PET;

BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; ESTRADIOL; FALSE POSITIVE REACTIONS; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY; RADIATION PNEUMONITIS;

EID: 84891485481     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-013-0761-1     Document Type: Article

References (18)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
2. Clark GM, Sledge GW Jr, Osborne CK, McGuire WL. Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol. 1987;5:55-61. (Pubitemid 17007856)
3. Rose C, Thorpe SM, Andersen KW, Pedersen BV, Mouridsen HT, Blichert-Toft M, et al. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet. 1985;1:16-9. (Pubitemid 15160544)
4. Bertelsen CA, Giuliano AE, Kern DH, Mann BD, Roe DJ, Morton DL. Breast cancers: estrogen and progesterone receptor status as a predictor of in vitro chemotherapeutic response. J Surg Res. 1984;37:257-63. (Pubitemid 15202608)
5. Amir E, Clemons M, Purdie CA, Miller N, Quinlan P, Geddie W, et al. Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies. Cancer Treat Rev. 2012;38:708-14.
6. Simmons C, Miller N, Geddie W, Gianfelice D, Oldfield M, Dranitsaris G, et al. Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases? Ann Oncol. 2009;20:1499-504.
7. Sundararajan L, Linden HM, Link JM, Krohn KA, Mankoff DA. 18F-Fluoroestradiol. Semin Nucl Med. 2007;37:470-6. (Pubitemid 47498260)
8. McGuire AH, Dehdashti F, Siegel BA, Lyss AP, Brodack JW, Mathias CJ, et al. Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma. J Nucl Med. 1991;32:1526-31.
9. Mintun MA, Welch MJ, Siegel BA, Mathias CJ, Brodack JW, McGuire AH, et al. Breast cancer: PET imaging of estrogen receptors. Radiology. 1988;169:45-8.
10. Peterson LM, Mankoff DA, Lawton T, Yagle K, Schubert EK, Stekhova S, et al. Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol. J Nucl Med. 2008;49:367-74. (Pubitemid 351355201)
11. van Kruchten M, Glaudemans AW, de Vries EF, Beets-Tan RG, Schröder CP, Dierckx RA, et al. PET imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemma. J Nucl Med. 2012;53:182-9.
12. Payne SJ, Bowen RL, Jones JL, Wells CA. Predictive markers in breast cancer - the present. Histopathology. 2008;52:82-90. (Pubitemid 350265187)
13. Sharangpani GM, Joshi AS, Porter K, Deshpande AS, Keyhani S, Naik GA, et al. Semi-automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer. J Microsc. 2007;226:244-55. (Pubitemid 47024246)
14. Pusztai L, Mazouni C, Anderson K, Wu Y, Symmans WF. Molecular classification of breast cancer: limitations and potential. Oncologist. 2006;11:868-77. (Pubitemid 44373759)
15. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28:2784-95.
16. Podoloff DA, Ball DW, Ben-Josef E, Benson AB 3rd, Cohen SJ, Coleman RE, et al. NCCN task force: clinical utility of PET in a variety of tumor types. J Natl Compr Canc Netw. 2009;7:S1-26.
17. Kovats S. Estrogen receptors regulate an inflammatory pathway of dendritic cell differentiation: mechanisms and implications for immunity. Horm Behav. 2012;62:254-62.
18. Bonds RS, Midoro-Horiuti T. Estrogen effects in allergy and asthma. Curr Opin Allergy Clin Immunol. 2013;13:92-9.